CIP
GMED icon

Chartwell Investment Partners’s Globus Medical GMED Stock Holding History

Chartwell Investment Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-64,900
Closed -$2.81M – 448
2018
Q4 		$2.81M Buy
64,900
+2,011
+3% +$100K 0.1% 277
2018
Q3 		$3.57M Buy
62,889
+88
+0.1% +$4.63K 0.1% 279
2018
Q2 		$3.17M Sell
62,801
-2,477
-4% -$129K 0.09% 288
2018
Q1 		$3.25M Buy
65,278
+19,460
+42% +$915K 0.11% 230
2017
Q4 		$1.88M Buy
+45,818
New +$1.6M 0.06% 332
2016
Q4 		– Sell
-250,402
Closed -$5.65M – 428
2016
Q3 		$5.65M Buy
250,402
+113,507
+83% +$2.67M 0.1% 235
2016
Q2 		$3.26M Sell
136,895
-58,200
-30% -$1.4M 0.06% 284
2016
Q1 		$4.63M Sell
195,095
-86,797
-31% -$2.12M 0.09% 207
2015
Q4 		$7.84M Sell
281,892
-279,005
-50% -$7M 0.16% 176
2015
Q3 		$11.6M Sell
560,897
-5,575
-1% -$141K 0.25% 131
2015
Q2 		$14.5M Sell
566,472
-312,976
-36% -$7.93M 0.28% 123
2015
Q1 		$22.2M Buy
879,448
+496,013
+129% +$12.1M 0.43% 74
2014
Q4 		$9.11M Sell
383,435
-127,845
-25% -$2.83M 0.19% 211
2014
Q3 		$10.1M Buy
511,280
+148,740
+41% +$3.06M 0.23% 178
2014
Q2 		$8.67M Sell
362,540
-72,037
-17% -$1.74M 0.18% 196
2014
Q1 		$11.6M Sell
434,577
-595,275
-58% -$14.1M 0.23% 166
2013
Q4 		$20.8M Buy
1,029,852
+23,070
+2% +$428K 0.43% 80
2013
Q3 		$17.6M Buy
1,006,782
+65,200
+7% +$1.13M 0.4% 85
2013
Q2 		$15.9M Buy
+941,582
New +$14.5M 0.4% 86

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Chartwell Investment Partners's GMED Position: Q1 2019 in Review

Chartwell Investment Partners sold out of Globus Medical (GMED) in Q1 2019, closing a stake of 64,900 shares — an estimated $2.81M sold.

Chartwell Investment Partners first reported a position in GMED in Q2 2013 and held it in 19 quarters. The position peaked at $22.2M in Q1 2015. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

  • Chartwell Investment Partners reported no remaining Globus Medical position as of Q1 2019 after selling out during the quarter.
  • Chartwell Investment Partners sold 64,900 Globus Medical shares in Q1 2019, an estimated $2.81M.
  • Chartwell Investment Partners first reported a position in Globus Medical in Q2 2013 and held it in 19 quarters.
  • Chartwell Investment Partners's Globus Medical position peaked at $22.2M in Q1 2015.
  • 269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on Chartwell Investment Partners's 13F filing for Q1 2019, filed 11 Apr 2019.